|
|
Volumn 4, Issue 1, 2003, Pages 30-36
|
|
What criteria for pharmaceuticals reimbursement? An empirical analysis of the evaluation of "medical service rendered" by reimbursable drugs in France
|
|
Author keywords
Drug evaluation; Drug utilization review; Economic evaluation; Medical service; Postregistration evaluation
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
ANXIOLYTIC AGENT;
CALCIUM;
HYPERTENSIVE AGENT;
HYPNOTIC AGENT;
IRON;
MAGNESIUM;
NEUROLEPTIC AGENT;
PHOSPHORUS;
POTASSIUM;
PSYCHOSTIMULANT AGENT;
PSYCHOTROPIC AGENT;
RETINOL;
SEDATIVE AGENT;
TRACE ELEMENT;
VASODILATOR AGENT;
VITAMIN B GROUP;
VITAMIN D;
ANALYTIC METHOD;
ANALYTICAL PARAMETERS;
ARTICLE;
COMMERCIAL PHENOMENA;
DATA ANALYSIS;
DECISION MAKING;
DISEASE SEVERITY;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
ECONOMIC ASPECT;
FRANCE;
MEDICAL SERVICE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REGISTRATION;
REIMBURSEMENT;
SAMPLING;
STATISTICAL ANALYSIS;
|
|
EID: 0037266610
PISSN: 16187598
EISSN: None
Source Type: Journal
DOI: 10.1007/s10198-002-0145-2 Document Type: Article |
|
Times cited : (27)
|
|
References (10)
|
